Le Roux Gaël, Bruneau Chloé, Lelièvre Bénédicte, Bretaudeau Deguigne Marie, Turcant Alain, Harry Patrick, Boels David
CHU d'Angers, Poison Control Center Angers University Hospital, Poison Control Center, 4 rue larrey, Angers 49933, France.
CHU d'Angers, Poison Control Center Angers University Hospital, Poison Control Center, 4 rue larrey, Angers 49933, France.
Drug Alcohol Depend. 2015 Sep 1;154:46-53. doi: 10.1016/j.drugalcdep.2015.05.048. Epub 2015 Jul 3.
Over the last decade, use of phenethylamines has become increasingly prevalent. This study aimed to describe typical aspects of phenethylamine poisoning in order to better inform patient care.
Phenethylamine poisoning cases reported to the Poison Control Center of Angers, France, from January, 2007 to December, 2013 were examined. Clinical findings were examined in 105 patients, including phenethylamine used, symptoms and final outcome. Patients were predominantly male (80%), with mean age 26±8 years.
MDMA (38%), amphetamine (18%) and methamphetamine (14%) were the most commonly reported. Synthetic cathinones (10%) and the 2C series (7%) were also found. Substances most commonly associated with phenethylamine poisoning were cannabis (27%), ethanol (20%) and cocaine (9%). The most frequently reported symptoms included anxiety and hallucinations (49%), mydriasis and headache (41%), tachycardia (40%) and hypertension (15%). Complications such as seizures (7%), cardiac arrest (5%), toxic myocarditis (1%) and hemorrhagic stroke (1%) were also observed. Of the cases, the Poison Severity Score was: null or low, 66%, moderate, 21%, severe or fatal, 13%. Of the patients, 77% received hospital care and 12.4% were admitted to an intensive care unit. Analytical confirmations were obtained for all severe cases. While 93% of patients recovered, there were 5 deaths and 2 patients presented with neurological sequelae.
Phenethylamine poisonings may be severe in young and healthy individuals. Physicians, toxicologists and analysts should be aware of new phenethylamine consumption trends in order to inform management of patient care and to contribute to a more responsive drug policy.
在过去十年中,苯乙胺的使用日益普遍。本研究旨在描述苯乙胺中毒的典型特征,以便为患者护理提供更充分的信息。
对2007年1月至2013年12月期间向法国昂热中毒控制中心报告的苯乙胺中毒病例进行了检查。对105例患者的临床发现进行了检查,包括所使用的苯乙胺、症状和最终结果。患者以男性为主(80%),平均年龄26±8岁。
最常报告的是摇头丸(38%)、苯丙胺(18%)和甲基苯丙胺(14%)。还发现了合成卡西酮(10%)和2C系列(7%)。与苯乙胺中毒最常相关的物质是大麻(27%)、乙醇(20%)和可卡因(9%)。最常报告的症状包括焦虑和幻觉(49%)、瞳孔散大和头痛(41%)、心动过速(40%)和高血压(15%)。还观察到癫痫发作(7%)、心脏骤停(5%)、中毒性心肌炎(1%)和出血性中风(1%)等并发症。在这些病例中,中毒严重程度评分情况为:无或低,66%;中度,21%;重度或致命,13%。77%的患者接受了住院治疗,12.4%的患者被收入重症监护病房。所有重症病例均获得了分析确认。虽然93%的患者康复,但有5例死亡,2例患者出现神经后遗症。
苯乙胺中毒在年轻健康个体中可能很严重。医生、毒理学家和分析人员应了解苯乙胺的新消费趋势,以便为患者护理管理提供信息,并有助于制定更具响应性的毒品政策。